Open Beta
TREN
MetriLume
TREN

US marketsMGRX

SEC-sourced researchBeta

MGRX

MANGOCEUTICALS, INC.

Company comparison ↗

Data passport

CIK
0001938046
Exchange
Nasdaq
Business activity
— · SIC 8090
Financial inputs
6/6
Filing date
Oct 6, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 615,873.0000 USD; December 2025: 456,021.0000 USD615.9K USD0 USD0December 2024December 2025
MGRX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2024615,873.0000Apr 1, 2026
December 2025456,021.0000Apr 1, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025456,021.0000-20,642,994.0000-5,850,255.000016,089,573.0000890,568.0000Apr 1, 2026
December 2024615,873.0000-8,706,145.0000-4,863,776.000015,370,511.00001,425,463.0000Apr 1, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$456.02KDecember 2025Apr 1, 202610-K
Previous period revenueRevenues$615.87KDecember 2024Apr 1, 202610-K
Net incomeNetIncomeLoss-$20.64MDecember 2025Apr 1, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$5.85MDecember 2025Apr 1, 202610-K
Total assetsAssets$16.09MDecember 2025Apr 1, 202610-K
Total liabilitiesLiabilities$890.57KDecember 2025Apr 1, 202610-K

New filings

Explore methodology ↗